Biophore
- Hyderabad
Hyderabad-based Zenara launches ‘Paxen’ tablets for COVID-19
Hyderabad: City-based Zenara Pharma, a subsidiary of Biophore India Pharmaceuticals, launched Nirmatrelvir and Ritonavir tablets as a treatment option for patients with mild to moderate symptoms of Covid-19. The CDSCO-approved tablet will…
- Hyderabad
Hyd-based Biophore seeks DCGI approval for use of Aviptadil in COVID treatment
Hyderabad: Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of…
